Email ID
Sign me in automatically next time
Consider Lilly: why the gloomy guidance?

Greater pessimism over generic erosion of Zyprexa sales and higher spending on SG&A are the principal reasons that Lilly's financial guidance for 2012, issued on 5 January, falls short of...
06 January 2012
Eleanor Malone

Please Login to read the full article.
04 April 2016
Stockholm, Sweden
06 April 2016
Hamburg, Germany
JOB OF THE WEEK Promote your job vacancy
© 2016 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36